Your browser doesn't support javascript.
loading
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML.
Tettero, Jesse M; Buisman, Yara; Ngai, Lok Lam; Bachas, Costa; Gjertsen, Bjorn T; Kelder, Angèle; van de Loosdrecht, Arjan A; Manz, Markus G; Pabst, Thomas; Scholten, Willemijn; Ossenkoppele, Gert J; Cloos, Jacqueline; de Leeuw, David C.
Afiliação
  • Tettero JM; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Buisman Y; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Ngai LL; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Bachas C; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Gjertsen BT; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Kelder A; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Manz MG; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Pabst T; Haukeland University Hospital, Bergen, Norway.
  • Scholten W; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Ossenkoppele GJ; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Cloos J; Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
  • de Leeuw DC; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
Hemasphere ; 7(12): e981, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38026789

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article